Viewing Study NCT05113368


Ignite Creation Date: 2025-12-24 @ 5:30 PM
Ignite Modification Date: 2026-02-22 @ 6:45 PM
Study NCT ID: NCT05113368
Status: RECRUITING
Last Update Posted: 2025-08-21
First Post: 2021-09-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Sponsor: Sarah K. Lynam MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module